Medicare's hospital readmissions reduction program and the rise in observation stays

Health Serv Res. 2023 Jun;58(3):554-559. doi: 10.1111/1475-6773.14142. Epub 2023 Feb 27.

Abstract

Objective: To evaluate whether Medicare's Hospital Readmissions Reduction Program (HRRP) is associated with increased observation stay use.

Data sources and study setting: A nationally representative sample of fee-for-service Medicare claims, January 2009-September 2016.

Study design: Using a difference-in-difference (DID) design, we modeled changes in observation stays as a proportion of total hospitalizations, separately comparing the initial (acute myocardial infarction, pneumonia, heart failure) and subsequent (chronic obstructive pulmonary disease) target conditions with a control group of nontarget conditions. Each model used 3 time periods: baseline (15 months before program announcement), an intervening period between announcement and implementation, and a 2-year post-implementation period, with specific dates defined by HRRP policies.

Data collection/extraction methods: We derived a 20% random sample of all hospitalizations for beneficiaries continuously enrolled for 12 months before hospitalization (N = 7,162,189).

Principal findings: Observation stays increased similarly for the initial HRRP target and nontarget conditions in the intervening period (0.01% points per month [95% CI -0.01, 0.3]). Post-implementation, observation stays increased significantly more for target versus nontarget conditions, but the difference is quite small (0.02% points per month [95% CI 0.002, 0.04]). Results for the COPD analysis were statistically insignificant in both policy periods.

Conclusions: The increase in observation stays is likely due to other factors, including audit activity and clinical advances.

Keywords: Medicare; difference-in-differences; hospital readmissions reduction program; inpatient; observation stays; recovery audit contractors.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Fee-for-Service Plans
  • Heart Failure* / therapy
  • Hospitalization
  • Humans
  • Medicare
  • Patient Readmission
  • Pulmonary Disease, Chronic Obstructive* / therapy
  • United States